Skip to Content

Sebelipase alfa

In the US, Sebelipase alfa (sebelipase alfa systemic) is a member of the drug class lysosomal enzymes and is used to treat Lysosomal Acid Lipase Deficiency.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AB14

CAS registry number (Chemical Abstracts Service)

1276027-63-4

Chemical Formula

C1968-H2945-N507-O551-S15

Molecular Weight

43003

Therapeutic Category

Enzyme replacement therapy

Chemical Name

Human lysosomal acid lipase/cholesteryl ester hydrolase (cholesteryl esterase, lipase A, EC=3.1.1.13) glycosylated (produced in trangenic Gallus) (WHO)

Foreign Names

  • Sebelipasum alfa (Latin)
  • Sebelipase alfa (German)
  • Sébélipase alfa (French)
  • Sebelipasa alfa (Spanish)

Generic Names

  • Sebelipase alfa (OS: USAN, JAN)
  • SBC-102 (IS)
  • UNII-K4YTU42T8G (IS)

Brand Names

  • KANUMA
    Alexion, Germany; Alexion Pharmaceuticals UK, United Kingdom
  • Kanuma
    Alexion, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide